Lifespan.io reports back from Aging Research and Drug Discovery Meeting (ARDD 2023)
Lifespan.io (LEAF) - 26-Sep-2023Key points from Arkadi Mazin's summary of 5 days of talks by geroscientists and biotech leaders
CEO of Ichor Therapeutics focussed on drug discovery that impacts the pathways of aging
Dr. Moody is a process-oriented drug developer and executive who has specialized in the study of aging and aging mechanisms for over a decade. Since 2013, Dr. Moody has successfully built Ichor Therapeutics from a living room start-up into a premier, vertically integrated research organization focused on drug discovery and development for pathways of aging.
Dr. Moody is a process-oriented drug developer and executive who has specialized in the study of aging and aging mechanisms for over a decade. Since 2013, Dr. Moody has raised over $30 million in venture capital and successfully built Ichor Life Sciences (formerly Ichor Therapeutics) from a living room start-up into a premier, vertically integrated research organization.
Visit website: https://ichorlifesciences.com/our-team/
See alsoDetails last updated 24-Oct-2019
Key points from Arkadi Mazin's summary of 5 days of talks by geroscientists and biotech leaders
Ichor Life Sciences leads the investment to advance anti-glycation therapies
Lento Bio research into molecular aging damage by accelerating clinical assets
Has cleared protein build up in vivo - has funding to develop clinical candidates
$16m raided, FoxBio partnership with Juvenescence, lots going on
28-Aug-2023 to 01-Sep-2023
Event about latest progress in the molecular, cellular and organismal basis of aging organized by University of Copenhagen
05-Nov-2022 to 06-Nov-2022
Healthy Masters conference about living longer and healthier life
Kelsey Moody, CEO of Ichor Life Sciences, shares updates on the company’s latest research
17-Aug-2023 to 20-Aug-2023
Club discount available - click here
Event gathering Global Longevity and Rejuvenation community in Dublin with many longevity movement superstars as speakers